View All Patents
EP1830843
INDOLIDONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
Filed
Dec 21, 2005
Technology
Chemistry · Pharmaceuticals
UPC cases
3
EPO proceedings
1
Ownership history
As recorded at the EPO. Transfers made after the opposition period are recorded in national registers and may be missing here.
Hover an owner to see their dates
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH; Boehringer Ingelheim Pharma GmbH & Co.KGsince Mar 11, 2011
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH; Boehringer Ingelheim Pharma GmbH & Co. KGMar 11, 2011 – Mar 11, 2011
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH; Boehringer Ingelheim Pharma GmbH & Co.KGAug 10, 2007 – Mar 11, 2011
Abstract
The present invention relates to the use of indolinones of general formula (I) substituted in the 6 position, wherein R₁ to R₅ and X are defined as in claim 1, the isomers and the salts thereof, particularly the physiologically acceptable salts thereof, as a medicament for the prevention or treatment of specific fibrotic diseases.
From the international application WO2006067165
Litigation history
| Date | Case | Division | Type | Outcome | Parties |
|---|---|---|---|---|---|
| Apr 10, 2026 | UPC CFI 858/2025 | Lisbon LD | Infringement | Locked | BOEHRINGER INGELHEIM INTERNATIONAL GMBH +1 |
Additional proceedings on this patent
Start 14-day free trialOutcomes, the additional proceedings and the register history.Already a user? Sign in